Non-amyloid liver involvement in familial Mediterranean fever: A systematic literature review.
Thibault FraisseLéa SaveyVéronique HentgenLinda Rossi-SemeranoIsabelle Koné-PautGilles GrateauStéphanie Ducharme-BénardStéphanie Ducharme-BénardPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
Despite a low prevalence of metabolic risk factors, FMF may be associated with NAFLD and cryptogenic cirrhosis as a consequence of chronic or recurrent inflammation. FMF patients should be regularly screened for liver injury. The latter may be prevented and treated by daily colchicine intake. The evidence was insufficient to establish an association with BCS, hyperbilirubinaemia or autoimmune hepatitis.